Related Experiment Video
Updated: Aug 6, 2026
07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
15.0K
Development of multi-epitope based subunit vaccine against Mycobacterium Tuberculosis using immunoinformatics
Savita Kumari R1, Guneswar Sethi1,2, Ramadas Krishna1
1Department of Bioinformatics, Pondicherry University, Puducherry, India.
Journal of Biomolecular Structure & Dynamics
|October 26, 2023
Summary
A novel multi-epitope subunit vaccine against tuberculosis (TB) was designed using computational methods. This vaccine shows promise for preventing TB infection and recurrence, with further in vitro and in vivo testing needed.
Area of Science:
- Immunology
- Computational Biology
- Vaccinology
Background:
- Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a global health challenge, exacerbated by increasing drug-resistant strains and the COVID-19 pandemic's impact on reporting.
- The WHO reported 10.6 million TB diagnoses and 1.6 million deaths globally in 2022, highlighting the urgent need for effective vaccines to combat the disease and achieve the End TB strategy.
- A robust TB vaccine is crucial for preventing primary infections and latent TB recurrence in adults and adolescents.
Purpose of the Study:
- To design a multi-epitope subunit vaccine against tuberculosis using computational approaches.
- To predict and integrate B-cell, helper T lymphocyte (HTL), and cytotoxic T lymphocyte (CTL) epitopes from key TB proteins.
- To computationally assess the vaccine's physicochemical properties, structure, immunogenicity, and expression potential.
Main Methods:
- Utilized computational techniques to predict HLA-binding epitopes from six Mycobacterium tuberculosis proteins.
- Designed a multi-epitope subunit vaccine by linking predicted epitopes with an LPA adjuvant.
- Performed physicochemical analysis, structural prediction and refinement, molecular docking (Tlr2, MHC-II), molecular dynamics simulations, MMPBSA analysis, immune simulation, and in silico cloning in E. coli.
Main Results:
- A multi-epitope subunit vaccine construct was designed, predicted to be non-allergic, non-toxic, and antigenic.
- The vaccine's binding affinity with immunogenic receptors (Tlr2 and MHC-II) was evaluated via molecular docking and dynamics simulations.
- In silico analysis indicated efficient expression of the designed vaccine in E. coli.
Conclusions:
- The study successfully designed a computationally optimized multi-epitope subunit vaccine against tuberculosis.
- The designed vaccine demonstrates favorable physicochemical properties and potential immunogenic attributes.
- Further in vitro and in vivo experimental validation is necessary to confirm the efficacy of this in silico developed vaccine.
